Related Experiment Video
Updated: Jul 15, 2026
07:52
Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents
Published on: June 2, 2015
Effects of ketamine on the developing central nervous system
László Vutskits1, Eduardo Gascon, József Zoltán Kiss
1Department of Anesthesiology, Pharmacology and Intensive Care, University Hospital of Geneva, Geneva, Switzerland.
Ideggyogyaszati Szemle
|April 25, 2007
Summary
Ketamine, used in pediatric anesthesia, may harm the developing brain by blocking NMDA receptors. This review examines evidence of ketamine
Area of Science:
- Neuroscience
- Anesthesiology
- Developmental Toxicology
Background:
- Ketamine is a common anesthetic in pediatric practice.
- It functions by blocking N-methyl-D-aspartate (NMDA) receptors.
- Emerging research suggests potential neurotoxic effects on the developing brain.
Purpose of the Study:
- To review experimental evidence of ketamine-induced developmental neurotoxicity.
- To discuss the limitations of applying animal study findings to human clinical practice.
Main Methods:
- Synopsis of laboratory-based experimental studies.
- Analysis of existing research on ketamine's effects on the central nervous system.
Main Results:
- Laboratory studies indicate that ketamine may adversely affect the developing central nervous system.
- Evidence suggests potential neurotoxic effects linked to NMDA receptor blockade.
Conclusions:
- Ketamine's use in pediatric anesthesia warrants careful consideration due to potential developmental neurotoxicity.
- Further research is needed to clarify the clinical relevance and implications of these experimental findings.
Related Concept Videos
01:24Parenteral Anesthetics: Overview
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
01:14CNS Depressants: Barbiturates and Benzodiazepines
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
01:12Local Anesthetics: Adverse Effects
While local anesthetics are generally safe and well-tolerated, they can occasionally cause adverse effects that vary in severity. Local anesthetics can induce toxicity at two distinct levels. They can either produce local effects through direct contact with the neural elements or be absorbed into the bloodstream from the injection site, leading to systemic effects.
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
01:23Sedatives and Hypnotics: Overview
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...